Invasive pneumococcal disease in the Czech Republic in 2000-2006;Invazivní pneumokokové onemocnění v České republice v letech 2000-2006

Epidemiologie, Mikrobiologie, Imunologie

Volumn 57, Issue 1, 2008, Pages 14-21

  Motlová, Jitka ^a   Benes C ^a   Krizova P ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

Coverage of serotypes by vaccines; Incidence; Invasive pneumococcal disease; Vaccination strategy

Indexed keywords

PNEUMOCOCCUS VACCINE;

ACTIVE IMMUNIZATION; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM ISOLATION; CZECH REPUBLIC; ENTEROCOCCUS; FATALITY; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; SEROTYPE; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; CHILD; CLASSIFICATION; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CZECH REPUBLIC; HUMANS; INFANT; MENINGITIS, PNEUMOCOCCAL; MIDDLE AGED; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 39049095055     PISSN: 12107913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bossen Konradsen, H., Staum Kaltoft, M. Invasive pneumococcal infections in Denmark from 1995 to 1999: Epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol 2002, 9, 358-365.
2. Dagan, R., Englehard, D., Piccard, E. Epidemiology of invasive childhood pneumococcal infections in Israel. JAMA 1992, 268, 3328-3332.
3. D'Ancona R et al. Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine 2005, 23, 2494-2500.
4. Escola, J. et al. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 1992, 268, 3323-3327.
5. Hammitt, L.L. et al. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: An explanation of trends in invasive pneumococcal disease. J. Infec Dis 2006, 193, 1487-1494.
6. Hausdorff, W.P. Invasive pneumococcal disease in children: Geographic and temporal variations in incidence and serotype distribution. Eur J Pediatr 2002, 161, 135-139.
7. Isaacman, D.J. et al. Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7, Prevnar). Vaccine 2007, 25, 2420-2427.
8. Ispahani P. et al. Twenty year surveillance of invasive pneumococcal disease in Nottingham: Serogroups responsible and implications for immunisation. Arch Dis Child 2004, 89, 757-762.
9. Kaltoft, M.S., Zeuthen, N., Konradsen, H.B. Epidemiology of invasive pneumococcal infections in children aged 0-6 years in Denmark: A 19-year nationwide surveillance study. Acta Paediatr 2000, 435, 3-10.
10. Lopalco, P. Editorial team. Use of 7-valent pneumococcal conjugate vaccine in EU. Euro Surveill 2006, 11(12):EO61207.3. Available from: http://www.eurosurveillance.org/ew/2006/061207.asp#3.
11. McIntosh, E.D.G., Pritzell, B., Fletcher, M.A. Burden of paediatric invasive pneumococcal disease in Europe, 2005. Epidemiol Infect 2006, 7, 1-13.
12. Miller E. et al. Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998. Acta Paediatr 2000, 89, 11-16.
13. Motlová, J. Distribuce sérotypů Streptococcus pneumoniae v České republice, duben 1995-prosinec 1998. Klin mikrobiol inf lék 1999, 2-3, 60-64.
14. Motlová, J. Distribuce sérotypu a séroskupin Streptococcus pneumoniae u pacientů s invazivními pneumokokovými onemocněními v České republice v letech 1996-2003: podklady pro vakcinační strategii. Epidemiol Mikrobiol Imunol 2005, 1, 3-10.
15. O'Brien, K.L., Dagan, R. The potential indirect effect of conjugate pneumococcal vaccines. Vaccine 2003, 21, 1815-1825.
16. Pebody, R.G. Pneumococcal vaccination policy in Europe. Euro Surveill 2005, 10, 174-178.
17. Pebody, R.G. et al. Pneumococcal disease surveillance in Europe. Euro Surveill 2006, 11, 171-178.
18. Pedersen, M.K. Systemic pneumococcal disease in Norway 1995-2001: Capsular types and antimicrobial resistance. Epidemiol Infect 2004, 132, 167-175.
19. Prymula, R. Současný pohled na konjugované pneumokokové vakcíny. Klin mikrobiol inf lék 2006, 3, 98-102.
20. Serrano, I, Ramirez, M., Melo-Cristino, J. Invasive Streptococcus pneumoniae from Portugal: Implications for vaccination and antimicrobial therapy. Clin Microbiol Infect 2004, 10, 652-656.
21. Spanjaard, L. et al. Epidemiology of meningitis and bacteremia due to Streptococcus pneumoniae in the Netherlands. Acta Paediatr Suppl 2000, 89, 22-26.
22. Venetz, I, Schopfer, K., Muhlemann, K. Paediatric invasive pneumococcal disease in Switzerland, 1985-1994. Int J Epidemiol 1998, 27, 1101-1104.
23. Vergison, A. et al. Epidemiologic features of invasive pneumococcal disease in Belgian children: Passive surveillance is not enough. Pediatrics 2006, 118, 801-809.
24. Von Kries, R. et al. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 2000, 31, 482-487.
25. Von Kries, R. et al. Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children. Pediatr Infect Dis J 2002, 21, 1017-1023.
26. WHO position paper: Pneumococcal conjugate vaccine for childhood immunization. Weekly Epidemiological Record 2007, 82, 93-104.